Differential (Click to cross reference) adverse drug reaction anti GQ1b IgG antibody arthralgia atypical autoimmune disease brain biopsy cancer associated myopathy carcinoma carcinoma of lung cardiotoxicity CAT scan, emission, abnormal cerebellitis cerebellitis, autoimmune chemotherapy, CNS treatment and complications with coinfection complications cranial nerve palsies creatine phosphokinase(CPK)elevated dentate nuclei dentate nuclei, lesion of diplopia dropped head syndrome drug induced neurologic disorders duvalumab dyspnea electromyogram encephalitis encephalitis, autoimmune Fisher's syndrome Guillain Barre syndrome hemiparesis hemiplegia, progressive hypercalcemia iatrogenic neurologic disorders immune checkpoint inhibitors immune-related adverse events immunosuppression immunosuppressive agents immunotherapy ipilimumab JC virus limb-girdle weakness lymph node biopsy lymphadenopathy melanoma, malignant misdiagnosis monoclonal antibodies MRI, abnormal MRI, contrast enhanced muscle biopsy muscle pain muscle weakness muscle weakness, proximal myasthenia gravis myasthenia gravis, drug induced myocarditis myopathy myopathy, inflammatory myopathy, necrotizing myopathy, necrotizing, immune-mediated myositis neck weakness neoplasm, metastatic neurologic complications of, systemic cancer neurologic disease, diagnoses of neurologic disease, multiple neuromuscular junction neuromuscular junction, abnormality of neuropathy neurotoxic nivolumab ocular motility, disorders of ophthalmoplegia opportunistic infection opportunistic infection, CNS paresthesias pembrolizumab pleocytosis of cerebrospinal fluid polymerase chain reaction, false negative prognosis progressive multifocal leucoencephalopathy progressive neurologic disorder ptosis ptosis, bilateral respiratory failure review article rhabdomyolysis sarcoidosis sarcoidosis, CNS seizure seronegative steroid steroid therapy, CNS treatment and complications with systemic illness treatment of neurologic disorder viral infection, CNS weakness white matter disease workup

Showing articles 0 to 10 of 10 Progressive Hemiparesis and White Matter Abnormalities in an HIV-Negative Patient Neurol 100:1156-1163, Jabbari,E.,et al, 2023 Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions Ann Neurol 89:1255-1256, Lambert, N.,et al, 2021 Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy NEJM 380:1597-1605, Cortese, I.,et al, 2019 GQ1b-Seronegative Miller Fisher Syndrome Associated with Pembrolizumab J Neuro-Ophthal 39:394-396, Green, K.E.,et al, 2019 Acute demyelinating polyneuropathy induced by nivolumab JNNP 89:435-437, Fukumoto, Y.,et al, 2018 Autoimmune Pancerebellitis Associated with Pembrolizumab Therapy Neurol 91:91-93, Vitt, J.R.,et al, 2018 Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer Neurol 91:e985-e994, Touat, M.,et al, 2018 Pembrolizumab-Induced Myasthenia Gravis Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018 Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016 Showing articles 0 to 10 of 10